Harvard Apparatus Regenerative Technology Inc. announced that it has entered into Securities Purchase Agreements with certain investors to issue an aggregate of 367,767 shares of common stock at a purchase price of $4.03 per share for the gross proceeds of $1,482,101.01 on April 15, 2024. The shares are issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under and/or Regulation D thereunder.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +3.11% | -5.69% | -53.51% |
1st Jan change | Capi. | |
---|---|---|
-53.51% | 33.21M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding